Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model

Full text for this resource is not available from the Research Repository.

Tan, Mei Lin, Friedhuber, Anna M and Dass, Crispin R (2013) Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model. Journal of Pharmacy and Pharmacology, 65 (1). pp. 35-43. ISSN 0022-3573 (print) 2042-7158 (online)

Abstract

Chitosan is a green (natural, abundant, biodegradable, biocompatible) biopolymer that can be formulated to encapsulate a variety of therapeutic compounds. This study aimed to investigate chitosan nanoparticles (NPs) as a means of improving delivery of the clinically used anti-cancer agent doxorubicin (Dox) and the preclinical lead compound Dz13 oligonucleotide together.

Dimensions Badge

Altmetric Badge

Item type Article
URI https://vuir.vu.edu.au/id/eprint/23713
DOI https://doi.org/10.1111/j.2042-7158.2012.01572.x
Official URL http://onlinelibrary.wiley.com/doi/10.1111/j.2042-...
Subjects Historical > Faculty/School/Research Centre/Department > School of Biomedical and Health Sciences
Historical > FOR Classification > 1112 Oncology and Carcinogenesis
Historical > FOR Classification > 1115 Pharmacology and Pharmaceutical Sciences
Keywords ResPubID26666, ResPubID25471, chemotherapy, chitosan, DNA, drug delivery, nanoparticles, cancer
Citations in Scopus 11 - View on Scopus
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login